Viewing Study NCT04298567


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-06-21 @ 3:57 PM
Study NCT ID: NCT04298567
Status: COMPLETED
Last Update Posted: 2024-06-28
First Post: 2020-02-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prevention of Atherothrombotic Events View
None Coronary Artery Disease (CAD) View
None Symptomatic Peripheral Artery Disease (Symptomatic PAD) View
Keywords: